AI-Driven Drug Discovery, Immunoinformatics, Digital Health
We are committed to the field of artificial intelligence (AI) for bioinformatics computing and digital health. By advancing the development and application of cutting-edge deep learning and large model technologies, we aim to tackle the complex diseases that humans face in their pursuit of high-quality health, such as obesity, diabetes, and tumors. Utilizing AI to the multi-omics and clinical big data, we strike to elucidate the high-order links between cellular phenotypes and underlying molecular mechanism. Meanwhile, we built generative large language models to accelerate the de novo design of small molecule drugs, antibodies and vaccines.
